Skip to Content

VIVUS 3.75/23 (Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg)

Generic Name: phentermine/topiramate

Pill with imprint VIVUS 3.75/23 is Purple, Capsule-shape and has been identified as Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg. It is supplied by Vivus, Inc..

Qsymia is used in the treatment of weight loss; obesity and belongs to the drug class anorexiants. Not for use in pregnancy. Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for VIVUS 3.75/23

Qsymia

Generic Name
phentermine/topiramate
Imprint
VIVUS 3.75/23
Strength
phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg
Color
Purple
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Anorexiants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Vivus, Inc.
National Drug Code (NDC)
62541-0201
Inactive Ingredients
sucrose, corn starch, microcrystalline cellulose, povidone k30, magnesium silicate, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 3

Note: Inactive ingredients may vary.

Submitted by: pillstress

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.